ILLUMINA, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
ILLUMINA, INC. (ILMN) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $17.00 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-12
- ILLUMINA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2025 was $17.00M, a 6.25% increase from fiscal 2024.
- ILLUMINA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $16.00M, a 48.39% decline from fiscal 2023.
- ILLUMINA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $31.00M, a 55.00% increase from fiscal 2023.
- ILLUMINA, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $20.00M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month |
|---|---|
| 2025-12-28 | $17.00M 10-K · filed 2026-02-12 |
| 2024-12-29 | $16.00M 10-K · filed 2026-02-12 |
| 2023-12-31 | $31.00M 10-K · filed 2026-02-12 |
| 2023-01-01 | $20.00M 10-K · filed 2025-02-12 |
| 2022-01-02 | -$10.00M 10-K · filed 2024-02-16 |
| 2021-01-03 | -$18.00M 10-K · filed 2023-02-17 |
| 2019-12-29 | -$20.00M 10-K · filed 2022-02-18 |
| 2018-12-30 | -$24.00M 10-K · filed 2021-02-17 |
| 2017-12-31 | -$41.00M 10-K · filed 2020-02-11 |
| 2017-01-01 | $3.00M 10-K · filed 2019-02-12 |
| 2016-01-03 | $2.00M 10-K · filed 2018-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |